Pacer Advisors
VIVO

Pacer Advisors’s Meridian Bioscience Inc VIVO Stock Holding History

Pacer Advisors’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-143,325
Closed -$4.52M – 3375
2022
Q3 		$4.52M Buy
143,325
+14,489
+11% +$469K 0.03% 362
2022
Q2 		$3.92M Buy
+128,836
New +$3.48M 0.03% 388
2020
Q2 		– Sell
-5,407
Closed -$59K – 1011
2020
Q1 		$59K Sell
5,407
-6,356
-54% -$53.5K ﹤0.01% 536
2019
Q4 		$115K Sell
11,763
-2,971
-20% -$27.9K 0.01% 1147
2019
Q3 		$140K Buy
14,734
+2,354
+19% +$24.8K ﹤0.01% 1109
2019
Q2 		$147K Buy
+12,380
New +$149K ﹤0.01% 1077
2018
Q1 		– Sell
-753
Closed -$11K – 1145
2017
Q4 		$11K Sell
753
-329
-30% -$4.82K ﹤0.01% 1141
2017
Q3 		$15K Buy
+1,082
New +$15.5K ﹤0.01% 1173

Other funds holding VIVO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
NAM
Nexpoint Asset Management Dallas, Texas $1.49B AUM 61.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Pacer Advisors's VIVO Position: Q4 2022 in Review

Pacer Advisors sold out of Meridian Bioscience Inc (VIVO) in Q4 2022, closing a stake of 143,325 shares — an estimated $4.52M sold.

Pacer Advisors first reported a position in VIVO in Q3 2017 and held it in 8 quarters. The position peaked at $4.52M in Q3 2022. 218 funds tracked by Wall St. Rank hold VIVO as of Q4 2022.

  • Pacer Advisors reported no remaining Meridian Bioscience Inc position as of Q4 2022 after selling out during the quarter.
  • Pacer Advisors sold 143,325 Meridian Bioscience Inc shares in Q4 2022, an estimated $4.52M.
  • Pacer Advisors first reported a position in Meridian Bioscience Inc in Q3 2017 and held it in 8 quarters.
  • Pacer Advisors's Meridian Bioscience Inc position peaked at $4.52M in Q3 2022.
  • 218 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q4 2022.

Based on Pacer Advisors's 13F filing for Q4 2022, filed 6 Feb 2023.